Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.
mikeelogan

Viaderma, Inc., To Initiate Upcoming Field Trial Of Comparison For Onychomycosis - Yahoo Finance

Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation - Yahoo Finance

AMR Cleanstethoscope ( VDRM ) (The Company), a specialty pharmaceutical company devoted to bringing new products to market, is excited to start participating in test trials with a major Food and Drug Administration (FDA) approved toenail fungus treatment. Onychomycosis is a fungal infection of the toenails or fingernails that may involve any part of the nail itself. This infection can cause pain, distress, and deformity that could sites produce serious physical and occupational restrictions, as well as affect quality of life.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/viaderma-inc-initiate-upcoming-field-141701919.html

SNGX: Updated skin mrsa Preclinical Data on RiVax Presented - Yahoo Finance

About XYDALBA XYDALBA is a second generation, semi-synthetic lipoglycopeptide, which consists of a lipophilic side-chain added to an enhanced glycopeptide backbone. XYDALBA is the first and only IV antibiotic approved for the treatment of ABSSSI with a two-dose regimen of 1000 mg followed one week later by 500 mg, each administered over 30 minutes. XYDALBA demonstrates bactericidal activityin vitroagainst a range of Gram-positive bacteria, such asStaphylococcus aureus (including methicillin-resistant, also known as MRSA, strains) andStreptococcus pyogenes, as well as certain other streptococcal species.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/actavis-receives-approval-european-commission-133000019.html

With his compelling background of success stories in hip arthroscopy, Dr. Matsuda is ideally positioned to lead this area of growth for us, said Dr. Bray. His recruitment reaffirms DISCs commitment to advance the role of minimally invasive surgery into new areas, giving us the ability to serve more complex, high-acuity cases. DISCs desire to build and support a fully-dedicated center of excellence for hip arthroscopy is very exciting to me, said Dr. Matsuda. As a former athlete myself, I have seen both sides of the scalpel, and it has been my career-long goal to further this area of sports medicine into new levels of patient care. Dr.
For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/03/prweb12550912.htm

DISC Sports & Spine Center Taps Dr. Dean K. Matsuda to Launch Hip Arthroscopy Center of Excellence

It's an opportunity to solve a very serious problem!" "With Cleanstethoscope, it is easier to disinfect your stethoscope after every use, further ensuring it is not contaminated," said Mike Taigman, general manager of AMR. "The healthcare industry has spent more than a century focused on building tools for clinicians so they can follow good infection control procedures.Cleanint builds good hygiene practices into the everyday systems of care, which makes it much easier for clinicians to do the right thing every time, all of the time." The Cleanhands will be worn by paramedics and EMTs ensuring that they will have instant access to an FDA approved hand disinfectant so they can further cut down the transmission of infectious diseases when moving from one patient to another in crisis situations or just a routine transport of a patient. AMR will be purchasing 50,000 AMR-branded Cleanstethoscope and Cleanhands units to be used by field personnel. Founded in 2009, Cleanint began with a singular concept: it's simple it's clean. This principle is at the heart of everything we develop. It means innovative products that perform flawlessly without getting in your way. It means practical solutions to let people work and play with complete peace of mind. It means learning from our customers how we can improve the quality of their lives through thoughtful designs.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/cleanint-rolls-cleanstethoscope-cleanhands-largest-140000295.html

Actavis Receives Approval from the European Commission for XYDALBA? (dalbavancin) - Yahoo Finance

Typical signs and symptoms may include pain in chest, bones, or joints; cough; mrsa and pneumonia skin infections, lungnodulesandpneumonia. Once a melioidosis is diagnosed, the disease can be treated with the use of appropriate antibiotics. The treatment of melioidosis is usually divided into two stages, an intravenous antibiotic therapy (high-intensity phase) for 10 to 14 days followed by a 3-6 months of oral antibiotic therapy (eradication phase) to prevent recurrence. During the intravenous intensive phase, ceftazidime is the current drug of choice for treatment of acute melioidosis. Combination therapy with ceftazidime, meropenem and imipenem is also used for the acute treatment. During the eradication phase, treatment withco-trimoxazoleanddoxycyclineis recommended to be used for 12 to 20 weeks to reduce the rate of recurrence. Current Challenges for Melioidosis Treatment Treatment with the above antibiotics can reduce mortality rate to 10% for uncomplicated cases, but still up to 80% for cases with bacteraemia or severe sepsis while mortality rate could exceed 90% without appropriate treatment.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/sngx-updated-preclinical-data-rivax-172500607.html

Don't be the product, buy the product!

Schweinderl